Peptide Database

A 15-amino acid peptide derived from human gastric juice. Studied for tissue repair, wound healing, tendon/ligament recovery, and gut protection.

A synthetic version of Thymosin Beta-4, a naturally occurring peptide involved in tissue repair, cell migration, and anti-inflammation.

A GLP-1 receptor agonist used for type 2 diabetes and weight management. One of the most studied peptides for metabolic health.

A dual incretin agonist targeting both GIP and GLP-1 receptors. Shows superior weight loss and glycemic control compared to GLP-1-only agonists.

A synthetic analog of growth hormone-releasing hormone (GHRH). Available with or without Drug Affinity Complex (DAC) which extends half-life.

A selective growth hormone secretagogue (GHS) that stimulates GH release without significantly affecting cortisol, prolactin, or ACTH.

A naturally occurring copper tripeptide found in human plasma, saliva, and urine. Declines with age. Studied for skin rejuvenation, wound healing, and hair growth.

A synthetic tetrapeptide studied for anti-aging properties through telomerase activation and pineal gland function regulation.

A synthetic analog of tuftsin with anxiolytic and nootropic properties. Used for anxiety, cognitive enhancement, and immune modulation.

A synthetic analog of ACTH(4-7) with neuroprotective and cognitive-enhancing properties. Used for stroke recovery and cognitive disorders.

A melanocortin receptor agonist FDA-approved for hypoactive sexual desire disorder. Works on the central nervous system rather than the vascular system.

A synthetic melanocortin peptide analog that stimulates melanogenesis (tanning) and has secondary effects on sexual function and appetite.

A modified fragment of human growth hormone (amino acids 177-191) that stimulates lipolysis without the growth-promoting or diabetogenic effects of full GH.

A neuropeptide that promotes delta-wave sleep and has stress-protective, analgesic, and endocrine-modulating properties.

A human cathelicidin antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi. Also modulates immune response.

The first 29 amino acids of GHRH. Stimulates natural GH production and release from the pituitary. Considered a more physiological approach than exogenous GH.

A thymic hormone essential for T-cell differentiation and immune regulation. Declines significantly with age as thymus involutes.

A triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Shows the highest weight loss of any obesity drug in trials.

A long-acting amylin analog being developed in combination with semaglutide (CagriSema) for obesity and type 2 diabetes treatment.

A synthetic GHRH analog FDA-approved for reducing excess abdominal fat in HIV-associated lipodystrophy. Also studied for cognitive benefits and NAFLD.

A first-generation growth hormone secretagogue that stimulates GH release via the ghrelin receptor. Known for strongly increasing appetite.

A second-generation growth hormone secretagogue with the strongest GH release of the GHRP family. Less appetite stimulation than GHRP-6.

The most potent GHRP for acute GH release but subject to desensitization with chronic use. Also has cardioprotective properties independent of GH.

An orally active, non-peptide growth hormone secretagogue. Mimics ghrelin to stimulate sustained GH and IGF-1 elevation over 24 hours.

A hypothalamic neuropeptide that stimulates GnRH release, triggering LH and FSH secretion. Being studied for reproductive medicine and as a diagnostic tool.

Synthetic gonadotropin-releasing hormone identical to endogenous GnRH. Used diagnostically and to maintain fertility during testosterone therapy.

A critical coenzyme found in every cell, involved in energy metabolism, DNA repair, and sirtuin activation. Declines significantly with age.

A mitochondria-derived peptide that regulates metabolic homeostasis. Acts as an exercise mimetic, improving insulin sensitivity and fat metabolism.

A mitochondria-derived peptide with cytoprotective effects. Protects against oxidative stress, apoptosis, and neurodegenerative processes. Declines with age.

A mitochondria-targeted tetrapeptide that concentrates 1000x in the inner mitochondrial membrane. Restores bioenergetics and reduces oxidative damage.

An angiotensin IV analog reported to be 10 million times more potent than BDNF at promoting new synapse formation. Under investigation for cognitive disorders.

A short bioregulatory peptide targeting bronchial and lung tissue. Part of the Khavinson peptide bioregulators developed at the St. Petersburg Institute of Bioregulation.

A 28-amino acid neuropeptide with potent anti-inflammatory, immunomodulatory, and vasodilatory properties. Being studied for CIRS, pulmonary conditions, and autoimmune diseases.

A C-terminal tripeptide fragment of alpha-MSH with potent anti-inflammatory properties. Being studied for gut inflammation, IBD, and skin conditions.

A complex of polypeptides extracted from calf thymus glands. Used in Russia for immune restoration, particularly in immunodeficient states and cancer adjuvant therapy.

An 8-amino acid peptide that reduces wrinkle depth by inhibiting SNARE complex formation, reducing neurotransmitter release at the neuromuscular junction. A 'topical Botox' concept.

The base tripeptide that can chelate copper. When copper-free, still shows gene-resetting properties, resetting ~4,000 genes toward a healthier expression pattern.

A senolytic peptide that selectively destroys senescent (zombie) cells by disrupting the FOXO4-p53 interaction that keeps them alive. The first peptide-based senolytic.

A semi-synthetic heparinoid compound used for interstitial cystitis and being studied for osteoarthritis. Provides glycosaminoglycan layer restoration and anti-inflammatory effects.